首页> 外文期刊>Journal of viral hepatitis. >Total and cause-specific mortality rates in a prospective study of community-acquired hepatitis C virus infection in northern Norway.
【24h】

Total and cause-specific mortality rates in a prospective study of community-acquired hepatitis C virus infection in northern Norway.

机译:在挪威北部社区获得性丙型肝炎病毒感染的前瞻性研究中,总死亡率和特定原因死亡率。

获取原文
获取原文并翻译 | 示例
           

摘要

Knowledge of the natural course and especially the total and cause-specific mortality of community-acquired chronic HCV infection is limited. The aims of our study were to determine the total and cause-specific mortality in patients infected with chronic hepatitis C in a community-based setting in northern Norway. This prospective cohort study included 1010 HCV-positive patients diagnosed with recombinant immunoblot assay between 1 January 1990 and 1 January 2000, with a median observation time from diagnosis to follow-up of 7 years. Data were collected from medical records in the period between 1 January 2004 and 30 June 2006. Time and cause of death were ascertained from the Norwegian Causes of Death Register. Age-adjusted death rates and standardised mortality ratios (SMRs) were compared with those of the general Norwegian population. In total, 122 deaths were recorded. The Kaplan-Meier estimate of survival was 88% at 14 years. The SMR in the cohort relative to the general population was 6.66. Most of the excess deaths in both genders were because of liver-related causes, those associated with a drug-using lifestyle and suicide. The statistically significant increase in SMRs ranged from 4.2 for death by cancer in women to 64.6 for liver disease in women. There was no statistically significant increase in SMRs from cardiovascular disease in either gender or from cancer in men. In conclusion, our study shows that the death rate in patients infected with hepatitis C is 6.66 times higher than in the general Norwegian population.
机译:对自然过程的了解,尤其是社区获得性慢性HCV感染的总死亡率和特定原因死亡率的知识是有限的。我们研究的目的是确定挪威北部以社区为基础的慢性丙型肝炎感染患者的总死亡率和特定病因死亡率。这项前瞻性队列研究包括1990年1月1日至2000年1月1日之间通过重组免疫印迹测定法诊断出的1010例HCV阳性患者,从诊断到随访的中位观察时间为7年。数据是从2004年1月1日至2006年6月30日期间的医疗记录中收集的。死亡时间和死因已从挪威死亡原因登记簿中查明。将年龄调整后的死亡率和标准化死亡率(SMR)与挪威普通人群的死亡率和标准化死亡率进行比较。总共记录了122人死亡。 Kaplan-Meier估计的14年生存率为88%。该队列相对于一般人群的SMR为6.66。男女双方的大多数超额死亡都是由于肝脏相关原因引起的,这些原因与吸毒的生活方式和自杀有关。 SMR的统计显着增加范围从女性因癌症死亡的4.2%到女性肝病的64.6%不等。无论是男性还是男性,心血管疾病引起的SMR均无统计学显着增加。总之,我们的研究表明,丙型肝炎患者的死亡率是挪威普通人群的6.66倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号